decline due to ␤-AR stimulation in these myocytes (24). In addition, a previous study in mice that had mutated PLB, which could not be phosphorylated (both Ser 16 and Thr 17 mutated to alanine), had no lusitropic effect during ␤-AR stimulation (5). Thus, PLB is an important mediator of Ca 2ϩ decline during ␤-AR stimulation. However, the faster [Ca 2ϩ ] i decline with ␤-AR stimulation may not only be due to PLB phosphorylation but the higher systolic Ca 2ϩ levels as well. Unlike these mentioned studies, we matched Ca 2ϩ transient peaks to best determine if the increase in systolic Ca 2ϩ and/or PLB phosphorylation contributed to the lusitropic effect during ␤-AR stimulation.
. SERCA's function is modulated by the regulatory protein, phospholamban (PLB), which inhibits SERCA function (26) . For example, transgenic mice with overexpression of PLB result in decreased SERCA activity and SR Ca 2ϩ uptake, which results in a slower Ca 2ϩ decline rate (19) . The PLB-mediated inhibition of SERCA can be relieved by its dissociation. An increase in Ca 2ϩ levels will cause this dissociation (20) . Thus, increasing the peak amplitude of the [Ca 2ϩ ] i transient will increase SERCA activity, which results in faster [Ca 2ϩ ] i decline rates (3) . PLB is also a major phosphoprotein in the myocyte. PLB can be phosphorylated on Ser 16 through protein kinase A (PKA) or on Thr 17 through Ca 2ϩ /calmodulin-dependent protein kinase (CAMKII). Phosphorylation at either site also results in the dissociation of PLB from SERCA. In fact, phosphorylation at these sites with ␤-adrenergic (␤-AR) stimulation in PLB overexpression mice normalizes the Ca 2ϩ decline compared with the wild type (WT) (19) . Furthermore, PLB knockout mice result in increased SERCA activity and SR Ca 2ϩ uptake, which results in faster Ca 2ϩ decline rates (25) . Interestingly, there was no further acceleration of the Ca 2ϩ decline due to ␤-AR stimulation in these myocytes (24) . In addition, a previous study in mice that had mutated PLB, which could not be phosphorylated (both Ser 16 and Thr 17 mutated to alanine), had no lusitropic effect during ␤-AR stimulation (5). Thus, PLB is an important mediator of Ca 2ϩ decline during ␤-AR stimulation. However, the faster [Ca 2ϩ ] i decline with ␤-AR stimulation may not only be due to PLB phosphorylation but the higher systolic Ca 2ϩ levels as well. Unlike these mentioned studies, we matched Ca 2ϩ transient peaks to best determine if the increase in systolic Ca 2ϩ and/or PLB phosphorylation contributed to the lusitropic effect during ␤-AR stimulation.
Because lowering the [Ca 2ϩ ] i is the initiating event that permits relaxation, clearly defining the processes contributing to Ca 2ϩ resequestation in the SR is important. Relaxation of the cardiac muscle is governed by processes at the myofilament level (17, 18) , and duration of activation is critically impacted by Ca 2ϩ transient kinetics. Thus, governing of Ca 2ϩ transient decline by the SR may have important clinical ramifications since relaxation is altered in many cardiomyopathies such as heart failure (31, 39) . Therefore, our purpose is to determine the major factor in the faster [Ca 2ϩ ] i decline during ␤-AR stimulation (i.e., the high systolic levels of [Ca 2ϩ ] i or PLB phosphorylation 
MATERIALS AND METHODS

Cardiomyocyte Isolation
Ventricular myocytes were isolated from mice (C57BL/6) (Jackson Laboratories, Bar Harbor, ME) as previously described (22) . Briefly, the heart was cannulated and hung on a Langendorff apparatus. It was then perfused with Ca 2ϩ -free Tyrode solution for 4 min. The solution was then switched to Tyrode solution containing Liberase Blendzyme II (0.077 mg/ml) (Roche Applied Science, Indianapolis, IN). After 3-5 min, the heart was taken down, the ventricles were minced, and myocytes were dissociated by trituration. Subsequently, the myocytes were filtered, centrifuged, and resuspended in Tyrode solution containing 200 mol/l Ca 2ϩ . Myocytes were used within 6 h of isolation. All of the animal protocols and procedures were performed in accordance with National Institutes of Health guidelines and approved by the Institutional Laboratory Animal Care and Use Committee at The Ohio State University.
Measurement of myocyte Ca 2ϩ transients. Ca 2ϩ transient measurements were performed as previously described (22) . Briefly, myocytes were loaded at room temperature with fluo 4-AM (10 mol/l; Molecular Probes, Eugene, OR) for 30 min, and then another 30 min were allowed for intracellular deesterification. The solution for deesterification was Tyrode solution containing 200 mol/l Ca 2ϩ . The instrumentation used for cell fluorescence measurements was a Cairn Research Limited (Faversham, UK) epifluorescence system. [Ca 2ϩ ]i was measured by fluo 4 epifluorescence with excitation at 480 Ϯ 20 nm and emission at 535 Ϯ 25 nm. The illumination field was restricted to collect the emission of a single cell. Data were expressed as ⌬F/F0, where F is the fluorescence intensity, and F0 is the intensity at rest. Myocytes were stimulated at 1 Hz via platinum electrodes connected to a Grass Telefactor S48 stimulator (West Warwick, RI).
Western blot analysis. Homogenized myocytes were used to measure specific phosphorylation at Ser 16 and Thr 17 (Badrilla, Leeds, UK) with phosphospecific antibodies and normalized to calsequestrin (ABR, Golden, CO) via Western blot analysis, as previously described (37 We further investigated this point by grouping the myocytes that had a higher maximum response to ISO together (n ϭ 14) and the myocytes that had a higher response to 3 mM [Ca 2ϩ ] o together (n ϭ 7). Shown in Fig. 5A, when grouping 75 , and RT 90 ). We also analyzed the time intervals between 25-50%, 50 -75%, and 75-90% (Fig. 6C) , as described above. The data in Fig. 6, B and C (Fig. 9B) . Therefore, the faster time to peak during ␤-AR stimulation with ISO is likely because of the activation of CAMKII.
DISCUSSION
Our data show that, when we compared matched systolic [Ca 2ϩ ] i levels with ISO and 3 mM [Ca 2ϩ ] o , PLB Ser 16 phosphorylation is the major factor for the faster Ca 2ϩ decline. Interestingly, this faster decline was only observed during the first 50% of the decline. ␤-AR stimulation also resulted in a faster Ca 2ϩ transient time to peak, which was prevented by CAMKII inhibition.
␤-AR stimulation. Stimulation of the ␤-AR pathway results in the classical positive inotropic and lusitropic effect (4) , that is, in terms of Ca 2ϩ handling, an increase in systolic [Ca 2ϩ ] i levels with a faster time to peak and decline. In mouse myocytes, the majority (Ͼ93%) of the Ca 2ϩ decline is the result of SR uptake via SERCA (2). SERCA is regulated by PLB. Ca 2ϩ binding to SERCA results in the dissociation of PLB from SERCA, which will result in enhanced activation. The higher [Ca 2ϩ ] i levels during ␤-AR stimulation should result in further dissociation of PLB from SERCA and faster Ca 2ϩ decline. It has been observed that, with higher systolic Ca 2ϩ levels, there is a faster Ca 2ϩ transient decline (3) . PLB is also a phosphoprotein and a key end target of the ␤-AR pathway. Thus, PKA phosphorylates PLB on Ser 16 (21) , and CAMKII phosphorylates PLB on Thr 17 . Phosphorylation of PLB also results in dissociation of PLB from SERCA. Hence, it is unknown which is the major factor accounting for the faster Ca 2ϩ transient decline during Ca 2ϩ decline rate (Fig. 1) . Interestingly, the decline rate with ISO was faster compared with 3 mM [Ca 2ϩ ] o . To be assured that the faster decline observed with ISO was the result of PLB phosphorylation and not the small difference in systolic Ca 2ϩ levels, we examined matched Ca 2ϩ transient amplitudes (Fig. 2) . Using the matched amplitudes, we investigated the time it took the Ca 2ϩ transient decline to reach 25, 50, 75, and 90% decline from its peak (Fig. 3A) . Our data show that, at each time point, the Ca 2ϩ decline rate was faster with ISO. We further analyzed these effects by examining various time intervals of the Ca 2ϩ transient decline. We measured the interval from 25-50%, 50 -75%, and 75-90% decline from its peak (Fig. 3B) . Interestingly, our data show that ISO resulted in a faster decline rate during the initial 50% of the decline. These results do not match our hypothesis that PLB phosphorylation would result in a faster decline during the final phase of the decline. Therefore, we now propose that systolic Ca 2ϩ levels in mouse myocytes, even during ␤-AR stimulation, do not reach the V max of the pump, but, during the first 50% of the decline, the dissociation constant between 3 mM [Ca 2ϩ ] o and ISO is at its greatest difference at this point. Furthermore, we were able to show that, at 300 nm [ ] i decline rates. We also examined the relationship between maximum systolic Ca 2ϩ levels and the Ca 2ϩ transient decline rate measured as RT 50 (Fig. 4) . Our data show that, with low Ser 16 phosphorylation, as systolic Ca 2ϩ levels increased there was a direct relationship for a faster Ca 2ϩ transient decline rate. This is consistent with a previous study (3) . There was a similar tendency when PLB Ser 16 was phosphorylated. However, when we examined the slopes of each line, the ISO value was considerably less than the 3 mM [Ca 2ϩ ] o value. Thus, the ISO group is less dependent upon Ca 2ϩ transient peak. In addition, the r 2 value for the ISO data indicated that we did not have a good fit. Thus, there is less of a correlation between Ca ] o and grouping together the myocytes that had a higher response to ISO (Fig. 5) (29) . However, this phosphorylation step occurred much slower (ϳ5 min) than Ser 16 phosphorylation. Given that we were using Ca 2ϩ transients that had matched amplitudes, we picked ISO-stimulated Ca 2ϩ transients before the peak was reached (ϳ2-3 min). With the short perfusion time and the lack of phosphatase inhibition or acidosis, CAMKII did not phosphorylate PLB and hence had no effect on ISO-stimulated Ca 2ϩ transient decline. Furthermore, similar to our conclusions, these authors showed that the lusitropic effect of ␤-AR stimulation correlated with PLB Ser 16 phosphorylation. Other factors that may contribute to Ca 2ϩ decline could be the Na ϩ /Ca 2ϩ exchanger (NCX) or troponin (Tn) I phosphorylation. NCX contributes to the Ca 2ϩ transient decline (2) . Studies have found that ␤-AR stimulation is able to enhance NCX current (30) . However, this is controversial, since others did not observe this effect (10) . Under our experimental conditions, we believe that NCX does not play a role in the effects of ␤-AR stimulation on Ca 2ϩ transient decay. NCX plays a minor role in the Ca 2ϩ decline rates in mouse myocytes (Ͻ5%); thus, this effect, if any, would be minor at best. (Fig. 9) . A previous study also observed that, with matched SR Ca 2ϩ loads and L-type Ca 2ϩ current, ISO also resulted in a faster rate of [Ca 2ϩ ] i rise and implicated the ryanodine receptor (RyR) (11) . Studies have shown that CAMKII can phosphorylate the RyR (12, 15, 27) . Additionally, studies have shown that, during ␤-AR stimulation, CAMKII phosphorylates the RyR to increase its activity (6, 8) . Our results with KN-93 may seem surprising in that CAMKII can affect Ca 2ϩ transient upstroke but not decline. However, a previous study found that there was a time course disparity in Thr 17 phosphorylation and RyR phosphorylation by CAMKII (16) . That is, with increasing frequency of stimulation, PLB Thr 17 phosphorylation did not change in the first 40 s and then linearly increased for 5 min. RyR Ser 2814 , the CaMKII site (although controversial), reached maximum phosphorylation after 90 s of increasing the frequency of stimulation. Although these measurements were performed using a different protocol than ours (force frequency vs. ␤-AR stimulation), there does appear to be a different time dependence to PLB and RyR CaMKII phosphorylation. Our data using ␤-AR stimulation are consistent with these results in that we observed an apparent effect of CaMKII on RyR function but not PLB function after 3 min. Thus, ␤-AR stimulation will activate CAMKII to likely increase RyR activity, which results in a faster Ca 2ϩ transient time to peak. The faster time to peak may also be because of faster SR Ca 2ϩ uptake. Nevertheless, a previous study found that transgenic mice overexpressing SERCA2a did not result in a faster Ca 2ϩ transient time to peak (13) . Our data are consistent with these observations, since our faster time to peak with ISO was prevented by CaMKII inhibition with KN-93. Yet, KN-93 had no effect on Ca 2ϩ transient decline rates. Thus, if increased SERCA activity was responsible for the faster time to peak, this effect would not have been prevented by KN-93.
Our study also has implications for other mediators of PLB phosphorylation in addition to the ␤-AR/PKA pathway [i.e., phosphatases, SERCA activators via glutathionylation (1), nitroxyl-induced nitrosylation of PLB (9), reactive nitrogen species, etc.]. For example, nitric oxide (NO) is an important regulator of cardiac contraction (38) . We have previously shown that neuronal NO synthase (NOS1) signaling targets PLB to modulate myocyte contraction (37 Some limitations of our study include only using one mouse strain. However, our previous work has shown no difference in force decline during ␤-AR stimulation in three different mouse strains (33) . Thus, we believe that our observations are valid for most (if not all) mouse strains. ␤-AR stimulation also increases heart rate. Increasing pacing frequency by itself also accelerates the Ca 2ϩ decline. However, this is independent of PLB phosphorylation and a separate mechanism (34) . Thus, we did not investigate the effects of pacing. In addition, we only used one ISO concentration. We believe using lower ISO concentrations will produce the same qualitative results, but not as great quantitatively. Furthermore, we believe that performing these experiments will not change our conclusion that PLB Ser 16 is the major factor for the faster Ca 2ϩ transient decline during ␤-AR stimulation.
In conclusion, we have shown that the major factor for the faster Ca 2ϩ decline during ␤-AR stimulation is PLB Ser 16 phosphorylation, which only occurs during the initial 50%. ␤-AR stimulation also results in a faster Ca 2ϩ transient time to peak that was dependent on CAMKII.
